TM6SF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.380860E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.661600E-02
Normal-vs-Stage2
2.875300E-03
Normal-vs-Stage3
9.714500E-02
Normal-vs-Stage4
7.960000E-02
Stage1-vs-Stage2
6.833400E-01
Stage1-vs-Stage3
2.867000E-01
Stage1-vs-Stage4
5.621200E-01
Stage2-vs-Stage3
2.357900E-03
Stage2-vs-Stage4
8.161000E-01
Stage3-vs-Stage4
8.518500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.618500E-04
Normal-vs-AfricanAmerican
1.248440E-01
Normal-vs-Asian
7.460900E-03
Caucasian-vs-AfricanAmerican
7.606000E-01
Caucasian-vs-Asian
1.621040E-01
AfricanAmerican-vs-Asian
3.907800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.000240E-03
Normal-vs-Female
3.919800E-03
Male-vs-Female
1.980380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.559500E-02
Normal-vs-Age(41-60Yrs)
1.571500E-02
Normal-vs-Age(61-80Yrs)
3.352800E-04
Normal-vs-Age(81-100Yrs)
2.756000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.086800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.572400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.295200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.877600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.939400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.002700E-03
Normal-vs-Daily Drinker
1.776120E-03
Normal-vs-Weekly Drinker
2.401900E-03
Normal-vs-Occasional Drinker
4.575500E-03
Normal-vs-Social Drinker
1.154050E-02
Non Drinker-vs-Daily Drinker
4.027800E-01
Non Drinker-vs-Weekly Drinker
8.795800E-01
Non Drinker-vs-Occasional Drinker
9.816400E-01
Non Drinker-vs-Social Drinker
5.820200E-01
Daily Drinker-vs-Weekly Drinker
3.147000E-01
Daily Drinker-vs-Occasional Drinker
3.875800E-01
Daily Drinker-vs-Social Drinker
1.708430E-01
Weekly Drinker-vs-Occasional Drinker
8.840400E-01
Weekly Drinker-vs-Social Drinker
6.513400E-01
Occasional Drinker-vs-Social Drinker
5.734200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.144400E-01
Normal-vs-Grade 2
5.384600E-01
Normal-vs-Grade 3
6.218000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.024000E-01
Grade 1-vs-Grade 3
7.651000E-01
Grade 1-vs-Grade 4
7.144400E-01
Grade 2-vs-Grade 3
6.986600E-01
Grade 2-vs-Grade 4
5.384600E-01
Grade 3-vs-Grade 4
6.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.786700E-04
Normal-vs-NonDiabetic
1.183860E-03
Diabetic-vs-NonDiabetic
8.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.180500E-04
Normal-vs-NoPancreatitis
1.717900E-03
Pancreatitis-vs-NoPancreatitis
5.834300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.352600E-04
Normal-vs-N1
4.184900E-03
N0-vs-N1
2.101200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.93229999998235E-06
Normal-vs-TP53-NonMutant
2.158900E-03
TP53-Mutant-vs-TP53-NonMutant
3.008300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
